193 related articles for article (PubMed ID: 8577953)
1. Utilizing uncertainty factors in minimal risk levels derivation.
Pohl HR; Abadin HG
Regul Toxicol Pharmacol; 1995 Oct; 22(2):180-8. PubMed ID: 8577953
[TBL] [Abstract][Full Text] [Related]
2. Health effects classification and its role in the derivation of minimal risk levels: developmental effects.
Pohl HR; Smith-Simon C; Hicks H
Regul Toxicol Pharmacol; 1998 Aug; 28(1):55-60. PubMed ID: 9784433
[TBL] [Abstract][Full Text] [Related]
3. Chemical risk assessment and uncertainty associated with extrapolation across exposure duration.
Pohl HR; Chou CH; Ruiz P; Holler JS
Regul Toxicol Pharmacol; 2010 Jun; 57(1):18-23. PubMed ID: 19944126
[TBL] [Abstract][Full Text] [Related]
4. Health effects classification and its role in the derivation of minimal risk levels: reproductive and endocrine effects.
Pohl HR; Luukinen B; Holler JS
Regul Toxicol Pharmacol; 2005 Jul; 42(2):209-17. PubMed ID: 15921838
[TBL] [Abstract][Full Text] [Related]
5. Health effects classification and its role in the derivation of minimal risk levels: hepatic effects.
Pohl HR; Chou CH
Regul Toxicol Pharmacol; 2005 Jul; 42(2):161-71. PubMed ID: 15869832
[TBL] [Abstract][Full Text] [Related]
6. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
Chou CH; Pohl HR
Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
[TBL] [Abstract][Full Text] [Related]
7. The use of hematological effects in the development of minimal risk levels.
Abadin HG; Murray HE; Wheeler JS
Regul Toxicol Pharmacol; 1998 Aug; 28(1):61-6. PubMed ID: 9784434
[TBL] [Abstract][Full Text] [Related]
8. The application of non-default uncertainty factors in the U.S. EPA's Integrated Risk Information System (IRIS). Part I: UF(L), UF(S), and "other uncertainty factors".
Stedeford T; Zhao QJ; Dourson ML; Banasik M; Hsu CH
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(3):245-79. PubMed ID: 17763048
[TBL] [Abstract][Full Text] [Related]
9. Public health guidance values for chemical mixtures: current practice and future directions.
Pohl HR; Hansen H; Chou CH
Regul Toxicol Pharmacol; 1997 Dec; 26(3):322-9. PubMed ID: 9441922
[TBL] [Abstract][Full Text] [Related]
10. Evaluating toxicologic end points to derive minimal risk levels for hazardous substances.
Chou CH; Williams M; Jones D; De Rosa CT
Int J Hyg Environ Health; 2002 Mar; 205(1-2):71-5. PubMed ID: 12018018
[TBL] [Abstract][Full Text] [Related]
11. Precision of estimates of an ADI (or TDI or PTWI).
Speijers GJ
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
[TBL] [Abstract][Full Text] [Related]
12. A procedure for developing risk-based reference doses.
Gaylor DW; Kodell RL
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
[TBL] [Abstract][Full Text] [Related]
13. Health effects classification and its role in the derivation of minimal risk levels: neurological effects.
Chou CH; Williams-Johnson M
Toxicol Ind Health; 1998; 14(3):455-71. PubMed ID: 9569449
[TBL] [Abstract][Full Text] [Related]
14. Proposal of new uncertainty factor application to derive tolerable daily intake.
Hasegawa R; Hirata-Koizumi M; Dourson ML; Parker A; Sweeney LM; Nishikawa A; Yoshida M; Ono A; Hirose A
Regul Toxicol Pharmacol; 2010 Nov; 58(2):237-42. PubMed ID: 20561553
[TBL] [Abstract][Full Text] [Related]
15. Health effects classification and its role in the derivation of minimal risk levels: immunological effects.
Abadin HG; Chou CH; Llados FT
Regul Toxicol Pharmacol; 2007 Apr; 47(3):249-56. PubMed ID: 17194513
[TBL] [Abstract][Full Text] [Related]
16. Health assessment of phosgene: approaches for derivation of reference concentration.
Gift JS; McGaughy R; Singh DV; Sonawane B
Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
[TBL] [Abstract][Full Text] [Related]
17. Chemical warfare agents: estimating oral reference doses.
Opresko DM; Young RA; Faust RA; Talmage SS; Watson AP; Ross RH; Davidson KA; King J
Rev Environ Contam Toxicol; 1998; 156():1-183. PubMed ID: 9597943
[TBL] [Abstract][Full Text] [Related]
18. A probabilistic effect assessment model for hazardous substances at the workplace.
Schneider K; Schuhmacher-Wolz U; Hassauer M; Darschnik S; Elmshäuser E; Mosbach-Schulz O
Regul Toxicol Pharmacol; 2006 Mar; 44(2):172-81. PubMed ID: 16356615
[TBL] [Abstract][Full Text] [Related]
19. Evolution of science-based uncertainty factors in noncancer risk assessment.
Dourson ML; Felter SP; Robinson D
Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):108-20. PubMed ID: 8933624
[TBL] [Abstract][Full Text] [Related]
20. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
